RXST:NASDAQRxSight, Inc. Analysis
Data as of 2026-05-23 - not real-time
$6.09
Latest Price
8/10Risk
Risk Level: High
Executive Summary
RxSight’s stock is trading well below its 20‑day (6.37), 50‑day (6.70) and 200‑day (8.66) moving averages, signaling a sustained bearish price trend. The RSI of 44 hints at a neutral‑to‑bearish momentum, while the MACD histogram shows a modest bullish tilt that has not yet translated into price recovery. Revenue has contracted 18% year‑over‑year to $30.9 M and operating margins remain deep in the red (‑57%), yet the company boasts a strong cash cushion of $218 M against modest debt of $10.8 M, giving it runway to fund R&D and market expansion. Recent milestones—over 300,000 Light Adjustable Lens implants and a modest EPS surprise—provide a narrative of commercial traction, but high volatility (68% 30‑day) and a beta of 1.6 underscore heightened market risk.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish technical positioning below key moving averages
- Elevated volatility and beta increasing price swings
- Negative cash flow and operating losses limiting near‑term upside
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Milestone of 300k LAL implants indicating market adoption
- Substantial cash reserves to support product rollout and FDA activities
- Analyst price targets clustering around $9‑$10, implying ~44% upside
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Unique, adjustable intra‑ocular lens technology with differentiated value proposition
- Potential for revenue growth as cataract surgery volumes recover post‑pandemic
- Undervalued book value (P/B < 1) offering a margin of safety over a multi‑year horizon
Key Metrics & Analysis
Financial Health
Revenue Growth-18.50%
Profit Margin-36.59%
P/E Ratio-10.9
ROE-17.06%
ROA-11.21%
Debt/Equity4.05
P/B Ratio0.9
Op. Cash Flow$-17570000
Free Cash Flow$-969250
Industry P/E27.6
Technical Analysis
TrendBearish
RSI43.9
Support$5.30
Resistance$7.49
MA 20$6.37
MA 50$6.70
MA 200$8.66
MACDBullish
VolumeDecreasing
Fear & Greed Index91.61
Valuation
Target Price$8.79
Upside/Downside44.38%
GradeUndervalued
TypeBlend
Risk Assessment
Beta1.59
Volatility68.07%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.